Close menu




September 14th, 2022 | 12:23 CEST

End of capitalism? Here comes growth! Mercedes-Benz, BrainChip, Amazon

  • Growth
  • Technology
  • Innovations
  • chips
Photo credits: pixabay.com

These days, the book The End of Capitalism by TAZ journalist Ulrike Herrmann is causing quite a stir. Its basic tenor is that the growth story is coming to an end. In order to achieve climate targets, it is now a matter of shrinking in the right way. Even if many readers might have spontaneously rolled their eyes at both the title and Ms Herrmann's employer, it is worth taking a closer look. Here is why the growth of the future offers opportunities.

time to read: 3 minutes | Author: Nico Popp
ISIN: MERCEDES-BENZ GROUP AG | DE0007100000 , BRAINCHIP HOLDINGS LTD | AU000000BRN8 , AMAZON.COM INC. DL-_01 | US0231351067

Table of contents:


    The end of capitalism? So argues the exciting book!

    Last week, when Ulrike Herrmann taught startup guru Frank Thelen the basics of economics and regretted that someone with so little expertise runs Thelen's companies, viewers stopped what they were doing. There is rarely so much entertainment on a public talk show! The author argues in a similarly bold manner in her book. On the one hand, she praises capitalism and emphasizes the advantages it has brought in recent decades. But capitalism cannot continue to exist if it cannot grow itself. The argumentation: In the wake of the climate crisis, scarce goods restrict growth and make downsizing necessary. This should run like the British wartime economy during the Second World War. At that time, the state rationed basic and raw materials. Citizens could choose between certain luxury goods through a kind of points system. Those who wanted more had to pay the price.

    Are we also threatened by such a planned economy? According to Herrmann, the world would have to choose between a planned shrinkage now and a crisis-like shrinkage later. The author denies that innovative solutions, such as modern chips or electricity storage systems, will eventually solve the problem. But there are good arguments! Moore's Law states that the complexity of integrated circuits regularly doubles with minimum component costs. Depending on the source, there is talk of 12, 18 or 24 months. Since, according to Moore's Law, computer chips and related technology are improving, so the world would do well not to pull the plug now as a precaution, as Ulrike Herrmann urges. In general, it remains unclear in the book how the state economy should be organized and how the world should shrink back to health. Not to mention the fact that state-planned economies are not exactly efficient as a rule.

    Chip industry as a beacon of hope - BrainChip combines sustainability and AI

    Mercedes-Benz Group, among others, shows that progress is moving forward in leaps and bounds. Just a few years ago, the carmaker was considered an inert dinosaur or a lame duck - the Swabians only had combustion engines on offer. Within a few years, Mercedes-Benz has set the lights to "green" and soon wants to be even more efficient electrically on the road thanks to new battery technology. AI is also playing an increasingly important role in the cars of the future. A few months ago, it became known that Mercedes was collaborating with BrainChip in addition to NVIDIA. The latter Company's chips have ensured, among other things, that power consumption around voice control in modern Mercedes cars has dropped significantly. In the future, even more chips will be installed. The consulting firm McKinsey sees a potential of 15% annually in the area of chips for the automotive industry.

    Daimler and Amazon: Good progress, but risks outweigh benefits

    AI also has great potential in logistics. When giant companies like Amazon make their processes better and better, this ultimately also has an effect on energy consumption. If, for example, courier trips are better planned or more synergy effects are created thanks to the analysis of data, productivity and climate protection increase in equal measure. According to Amazon, the increased use of AI and robots is creating more human jobs - just more skilled ones. However, Amazon's stock is hardly benefiting from this development. Last year, concerns about a recession dominated and determined share prices. When it comes to reconciling growth and sustainability, Amazon remains a crucial company. On the one hand, Amazon is big enough to make a difference; on the other, the giga-corporation is already well positioned for the future.


    The development of the Mercedes-Benz share over the past year also resembled a zero-sum game. However, if the value rises above the level of EUR 61, the chart picture could brighten. And AI chip pioneer BrainChip? The Company, whose semiconductors resemble the human brain and score points for low power consumption, has posted a healthy return of more than 100% over the past year. Nevertheless, the stock is still far from its highs. Since the value neither suffers directly from the current recession fear nor is strongly dependent on energy prices, but at the same time stands for necessary solutions, speculatively thinking investors should have BrainChip on their radar. The book by Ulrike Herrmann, which is critical of capitalism, should not be ignored entirely, even by convinced stock market investors. It provides important food for thought: If we want to achieve growth and sustainability at the same time, we cannot do it without innovations. It will be important to advance the right technology in the coming months and years. Chips are the key to many innovations.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Armin Schulz on October 4th, 2022 | 10:58 CEST

    JinkoSolar, TubeSolar, Encavis - Shares for the energy turnaround

    • agritech
    • renewableenergies
    • Technology

    The phase-out of fossil energy generation is a done deal in Germany, but there is still a long way to go. Germany's share of renewable energies in electricity generation was 42.4% in 2021. However, this covered only 19.7% of Germany's energy consumption. Since the flare-up of the Ukraine crisis, the expansion of renewable energies is to be accelerated. A balanced mix is essential. Spring and summer are the main times for solar power, while in fall and winter, when the days are shorter, wind power is the primary source of electricity. If we want to achieve the 2030 targets, a massive expansion is essential. Today we take a look at three renewable energy companies.

    Read

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read